SCHEMBL26641815

SCHEMBL26641815

O=C1CCN(c2ccc(N3CCNCC3)cc2Cl)C(=O)N1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRB1 P08588 6/20 0.54
▸ DDB1 Q16531 6/20 0.46
▸ CRBN Q96SW2 6/20 0.46
▸ HTR3E A5X5Y0 3/20 0.46
▸ HTR3B O95264 3/20 0.46
▸ HTR3A P46098 3/20 0.46
▸ HTR3D Q70Z44 3/20 0.46
▸ HTR3C Q8WXA8 3/20 0.46
▸ SIGMAR1 Q99720 3/20 0.46
▸ HTT P42858 2/20 0.46
▸ HTR6 P50406 2/20 0.46
▸ TP53 P04637 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ HTR1A P08908 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ THRB P10828 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ HTR2A P28223 1/20 0.46
▸ HTR2C P28335 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30266979 0.90 ADRB1 (0.54) ADRB1DDB1CRBNHTR3EHTR3B
SCHEMBL27039567 0.84 DDB1 (0.56) ADRB1DDB1CRBNHTR3EHTR3B
SCHEMBL27039415 0.84 CRBN (0.46) ADRB1DDB1CRBNHTR3EHTR3B
Hydrochloric Acid SCHEMBL30969010 0.83 DDB1 (0.55) ADRB1DDB1CRBNHTR3EHTR3B
SCHEMBL26641240 0.83 DDB1 (0.43) DDB1CRBNHTTTP53ALDH1A1
SCHEMBL31306692 0.82 DDB1 (0.56) ADRB1DDB1CRBNHTR3EHTR3B
SCHEMBL25824550 0.81 HTR1A (0.44) ADRB1DDB1CRBNHTR3EHTR3B
SCHEMBL26641696 0.81 HTR3E (0.43) ADRB1DDB1CRBNHTR3EHTR3B
SCHEMBL22119794 0.80 CRBN (0.65) ADRB1DDB1CRBNHTR3EHTR3B
SCHEMBL23983379 0.79 TYMP (0.39) DDB1CRBNHTTALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120092003-A CDK protein degrading agents, pharmaceutical compositions and therapeutic uses 拜欧斯瑞克斯公司 2025-06-03 — — CN disclosed
WO-2023220640-A1 CDK PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS BIOTHERYX, INC. (US) 2023-11-16 — — WO disclosed
Send feedback